ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1235

Rheum to Grow: Supporting Young Adults with Childhood-Onset Rheumatic Disease in Their Transition to Adult Care

Cindy Chiu1, Sadie Van den Bogaerde2, Maya Swaminathan3, Rebecca Sadun4 and Thomason Jenna1, 1University of Washington, Division of Rheumatology, Seattle, WA, 2University of Washington, Seattle, WA, 3MultiCare, Newcastle, WA, 4Duke University, Durham, NC

Meeting: ACR Convergence 2024

Keywords: education, patient, Health Care, Juvenile idiopathic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Patient Outcomes, Preferences, & Attitudes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Transitional care for patients with childhood-onset rheumatic disease is essential, as this transition is known to be a high-risk time for medication nonadherence, lapses in care, worsening mental health, and increased disease activity. Almost all guidance on this topic comes from the pediatric perspective; little is known about how adult rheumatology clinics can support patients through this process. 

Methods: All patients transitioning to adult care at one of three UW rheumatology sites were invited to complete a Transition Survey, which was comprised of the ACR Self-Care Assessment for Young Adults (assessing transition and self-care importance, confidence, health knowledge, and navigation of the healthcare system), plus additional questions regarding sexual/reproductive health and access to primary care and mental health services. Demographics, disease characteristics and time lapsed since last pediatric appointment were collected via chart review.  

Results: From February 2023 – May 2024, 28 eligible patients were identified; 14 (50%) completed the survey. Of those surveyed, 7 (50%) had JIA, 4 (28.6%) had SLE, 1 had CRMO, 1 had Behcet’s Syndrome, and 1 had ANCA vasculitis [Table 1]. Mean disease duration was 8.6 years (range 2 – 19 years) and average time since last pediatric rheumatology appointment was 7.6 months (range 1 – 36 months). Of those capable of becoming pregnant, 4 (33.3%) were on teratogenic medications, and half of the patients on teratogenic medications reported being on contraception. 

Half of those surveyed felt it was very important to take care of their health, but only 23.1% felt extremely confident in their ability. Most reported understanding how to schedule appointments, check in for appointments, and identify their type of health insurance. The majority (83.3%) were interested in educational resources explaining the differences between pediatric and adult rheumatology care. Respondents also noted interest in receiving information via social media. Only 21.4% felt they would benefit from a transition coordinator, whereas slightly more than half (57.1%) did not think they would benefit from this resource. Of those who felt they would benefit from a transition coordinator, the majority expressed low confidence in their ability to take care of their own health. 

Conclusion: There remains much to learn about how we can support young adults transitioning from pediatric to adult rheumatology care. Per the suggestions from our respondents, we produced educational videos detailing the transition timeline [Figure 1] and highlighting major differences between pediatric and adult care [Figure 2]. While some patients, particularly those with low confidence in their ability to care for their own health, may benefit from a transition coordinator, this resource may not be necessary for all youth transitioning to adult care.  

Supporting image 1

Supporting image 2

Figure 1. Video detailing a suggested timeline for patients with childhood-onset rheumatic disease transitioning from pediatric to adult rheumatology care. Use the QR code for access!

Supporting image 3

Figure 2. Video detailing the major differences between pediatric to adult rheumatology care. Use the QR code for access!


Disclosures: C. Chiu: None; S. Van den Bogaerde: None; M. Swaminathan: None; R. Sadun: None; T. Jenna: None.

To cite this abstract in AMA style:

Chiu C, Van den Bogaerde S, Swaminathan M, Sadun R, Jenna T. Rheum to Grow: Supporting Young Adults with Childhood-Onset Rheumatic Disease in Their Transition to Adult Care [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/rheum-to-grow-supporting-young-adults-with-childhood-onset-rheumatic-disease-in-their-transition-to-adult-care/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheum-to-grow-supporting-young-adults-with-childhood-onset-rheumatic-disease-in-their-transition-to-adult-care/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology